Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1993 Feb;56(2):197-200.
doi: 10.1136/jnnp.56.2.197.

A pilot trial of dextromethorphan in amyotrophic lateral sclerosis

H Askmark  1 , S M Aquilonius, P G Gillberg, L J Liedholm, E Stålberg, R Wuopio
Affiliations
Clinical Trial

A pilot trial of dextromethorphan in amyotrophic lateral sclerosis

H Askmark et al. J Neurol Neurosurg Psychiatry. 1993 Feb.

Abstract

Assuming the presence of glutamate-induced neurotoxicity in amyotrophic lateral sclerosis 14 patients were treated with dextromethorphan, an N-methyl-D-aspartate receptor antagonist. The patients were treated with 150 mg dextromethorphan or placebo daily for 12 weeks in a double-blind crossover trial, with a wash out period of 4 weeks between the two treatment periods. Thereafter the surviving patients were treated with 300 mg dextromethorphan daily for up to 6 months in an open trial. No positive effects on clinical or neurophysiological parameters (relative number of axons, and compound muscle action potentials in the abductor digiti minimi muscle) were observed either in the double-blind trial or in the open trial.

PubMed Disclaimer

References

    1. J Neurol Neurosurg Psychiatry. 1971 Apr;34(2):121-31 - PubMed
    1. Neurology. 1974 Aug;24(8):721-8 - PubMed
    1. J Neurol Neurosurg Psychiatry. 1974 Aug;37(8):907-15 - PubMed
    1. Muscle Nerve. 1982 Apr;5(4):291-301 - PubMed
    1. Ann Neurol. 1985 Aug;18(2):165-72 - PubMed

Publication types

Substances